UNSPSC 51434403: Mecamylamine hydrochloride

This classification denotes a nicotinic antagonist with the molecular formula C11H21N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4956DJR58O, chemically known as 3-beta-methylamino-2,2,3-trimethylbicyclo(2.2.1)heptane but more generally known as mecamylamine hydrochloride, which bears US NIH Compound Identifier 4032. European Medicines Agency schedules Mecamylamine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03104MIG.

Most nations, for tariff and trade purposes, schedule mecamylamine hydrochloride under HS 29213099 and SITC 51453. As of Q4 2014, MECAMYLAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Mecamylamine hydrochloride bears US NLM identifiers UMLS ID C0304526 and NCI Concept Code C66064. SMILES: CC1(C2CCC(C2)C1(C)NC)C.CL.

UNSPSC 51434403 Mecamylamine hydrochloride is a Commodity code that in practice covers advanced life support and emergency medical medications supplied to municipal fire rescue departments and state health agencies. State and local governments buy these drugs through sealed competitive bids (IFB) and cooperative purchasing RFPs to stock emergency medical kits, maintain pharmacy benefit programs, and supply direct-to-manufacturer prescription networks. Issuing bodies range from municipal purchasing departments—particularly fire rescue services—to state health and human services commissions managing pharmacy benefits for employee and public plans. The City of Tampa Fire Rescue and the Texas Health and Human Services Commission represent the mix of municipal and state-level demand currently visible under the code.

Recent activity clusters in Florida and Texas, with interstate cooperative purchasing extending to Minnesota and Oregon. The City of Tampa's IFB (26P00188, response due April 8, 2026) solicited advanced life support medications including epinephrine, labetalol, adenosine, and diltiazem for fire rescue operations with firm pricing and delivery within ten calendar days, estimated contract value $40,000 with a Small Local Business Enterprise sheltered market designation offering a 5 percent bid discount. The Texas HHS Commission issued a Request for Information (HHS0017013, posted April 3, 2026) to gauge vendor capacity for direct-to-manufacturer prescription fulfillment outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) posted an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with contract effectiveness July 1, 2026, and evaluation weighted 75 percent on price competitiveness, requiring cGMP certification and Drug Supply Chain Security Act compliance.